Personalis Announces Collaboration with MapKure to Use Personalis’ NeXT Platform™ for Clinical Trials and Companion Diagnostic Development
MENLO PARK, Calif.--(BUSINESS WIRE)--#immunooncology--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today…